Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
TLPH Stock Forecast 2026-2027
$1.33
Current Price
$68.77M
Market Cap
Buy 3
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to TLPH Price Targets
+164.2%
To High Target of $3.50
+126.4%
To Median Target of $3.00
+126.4%
To Low Target of $3.00
TLPH Price Momentum
-8.9%
1 Week Change
+22.0%
1 Month Change
+224.4%
1 Year Change
+16.7%
Year-to-Date Change
-15.6%
From 52W High of $1.57
+239.7%
From 52W Low of $0.39
📊 TOP ANALYST CALLS
Did TLPH Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if AcelRx is one of their latest high-conviction picks.
Latest TLPH Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, TLPH has a bullish consensus with a median price target of $3.00 (ranging from $3.00 to $3.50). The overall analyst rating is Strong Buy (9.3/10). Currently trading at $1.33, the median forecast implies a 126.4% upside. This outlook is supported by 3 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Brandon Folkes at HC Wainwright & Co., suggesting a 126.4% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
TLPH Analyst Ratings
3
Buy
0
Hold
0
Sell
TLPH Price Target Range
Low
$3.00
Average
$3.00
High
$3.50
Current: $1.33
Latest TLPH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for TLPH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 5, 2026 | HC Wainwright & Co. | Brandon Folkes | Buy | Assumes | $3.00 |
| Apr 30, 2026 | WestPark Capital | Buy | Initiates | $N/A | |
| Apr 1, 2025 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Jan 21, 2025 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Aug 16, 2024 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| May 15, 2024 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| May 6, 2024 | Maxim Group | Buy | Initiates | $N/A | |
| Mar 7, 2024 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Jan 22, 2024 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Dec 7, 2023 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Oct 2, 2023 | Alliance Global Partners | Buy | Initiates | $N/A | |
| Sep 25, 2023 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Aug 18, 2023 | HC Wainwright & Co. | Buy | Upgrade | $N/A |
Talphera Inc. (TLPH) Competitors
The following stocks are similar to AcelRx based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Talphera Inc. (TLPH) Financial Data
Talphera Inc. has a market capitalization of $68.77M with a P/E ratio of -3.9x. The company generates $1,000 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of -1,451,600.0% and return on equity of -118.4%.
Valuation Metrics
Market Cap
$68.77M
Enterprise Value
$55.46M
P/E Ratio
-3.9x
PEG Ratio
0.1x
Price/Sales
70,064.5x
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
-1,451,600.0%
Net Margin
0.0%
EPS Growth
-100.0%
Financial Health
Cash/Price Ratio
+30.7%
Current Ratio
5.3x
Debt/Equity
35.2x
ROE
-118.4%
ROA
-40.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Talphera Inc. (TLPH) Business Model
About Talphera Inc.
What They Do
Provides renewable energy solutions through wind and solar.
Business Model
Talphera Inc. generates revenue by designing, developing, and deploying scalable wind and solar power systems for both commercial and residential markets. The company also engages in infrastructure projects to modernize energy grids, enhancing energy distribution reliability and efficiency.
Additional Information
Recognized as a key player in the renewable sector, Talphera Inc. is committed to advancing environmental sustainability and economic growth, making significant contributions to reducing carbon footprints globally.
Company Information
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
12
CEO
Mr. Vincent J. Angotti
Country
United States
IPO Year
2011
Website
talphera.comTalphera Inc. (TLPH) Latest News & Analysis
Latest News
Quick Summary
Talphera, Inc. (TLPH) held its Q1 2026 earnings call, providing updates on financial performance and company developments. Further details on revenues and outlook were discussed.
Why It Matters
Talphera's Q1 2026 earnings report provides insights into its financial health and performance trends, influencing stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Talphera, Inc. reported cash and investments of $21.1 million as of March 31, 2026. A NEPHRO CRRT clinical study is expected to complete this year. A conference call is scheduled for May 13, 2026.
Why It Matters
Completion of the NEPHRO CRRT clinical study could lead to new product approval, impacting future revenues. Strong cash position indicates financial stability, influencing investor confidence.
Source: PRNewsWire
Market Sentiment:
Neutral
Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 13, 2026
2 months ago
Quick Summary
Talphera, Inc. (Nasdaq: TLPH) will release its Q1 2026 financial results on May 13, 2026, after market close, followed by a live webcast and conference call at 4:30 p.m.
Why It Matters
Talphera's upcoming financial results and conference call may influence stock performance and investor sentiment, providing insights into the company's growth and market strategy.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Talphera, Inc. (Nasdaq: TLPH) will present two abstracts at the International Conference on Advances in Critical Care Nephrology from March 29-April 2, 2026, in San Diego.
Why It Matters
Talphera's acceptance of abstracts at a major medical conference highlights its research credibility and potential for future innovations, which may drive stock value and investor interest.
Source: PRNewsWire
Market Sentiment:
Neutral
Talphera Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
3 months ago
Quick Summary
Talphera, Inc. achieved 50% enrollment in the NEPHRO CRRT clinical study, raised $4.1M, and reported $20.4M in cash as of December 31, 2025. An investor update is scheduled for March 23, 2026.
Why It Matters
Talphera's enrollment milestone and secured financing enhance its clinical study progress, potentially boosting investor confidence. Cash reserves indicate financial stability for ongoing operations.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Talphera, Inc. (TLPH) held an Analyst/Investor Day, providing updates on company performance and future strategies. Further details may impact investor decisions.
Why It Matters
The Analyst/Investor Day provides insights into Talphera's strategy, financial health, and growth prospects, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Frequently Asked Questions About TLPH Stock
What is Talphera Inc.'s (TLPH) stock forecast for 2027?
Based on our analysis of 2 Wall Street analysts, Talphera Inc. (TLPH) has a median price target of $3.00. The highest price target is $3.50 and the lowest is $3.00.
Is TLPH stock a good investment in 2027?
According to current analyst ratings, TLPH has 3 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $1.33. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for TLPH stock?
Wall Street analysts predict TLPH stock could reach $3.00 in the next 12 months. This represents a 126.4% increase from the current price of $1.33. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Talphera Inc.'s business model?
Talphera Inc. generates revenue by designing, developing, and deploying scalable wind and solar power systems for both commercial and residential markets. The company also engages in infrastructure projects to modernize energy grids, enhancing energy distribution reliability and efficiency.
What is the highest forecasted price for TLPH Talphera Inc.?
The highest price target for TLPH is $3.50 from at , which represents a 164.2% increase from the current price of $1.33.
What is the lowest forecasted price for TLPH Talphera Inc.?
The lowest price target for TLPH is $3.00 from Brandon Folkes at HC Wainwright & Co., which represents a 126.4% increase from the current price of $1.33.
What is the overall TLPH consensus from analysts for Talphera Inc.?
The overall analyst consensus for TLPH is bullish. Out of 2 Wall Street analysts, 3 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $3.00.
How accurate are TLPH stock price projections?
Stock price projections, including those for Talphera Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 18, 2026 7:58 AM UTC